Venkatakrishna Kakkilaya, M.D.
NPI 1386855161ActiveIndividual· Pediatrics, Neonatal-Perinatal Medicine· Dallas, TX
Pediatrics, Neonatal-Perinatal Medicine (M.D.) in Dallas, Texas, licensed in TX, with an NPI issued in May 2007. Enrolled in Medicare as practitioner - pediatric medicine. Chiesi USA, Inc. was the largest of 2 companies reporting payments in 2025, $7,145 in all, mostly consulting fees.
Overview
| NPI | 1386855161 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | May 24, 2007 |
| Last updated in NPPES | Oct 7, 2011 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Neonatal-Perinatal Medicine Primary | 2080N0001X | N9078 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pediatric Medicine (TX) |
|---|
Industry payments (Open Payments)
- 2025$7,145 · 3 payments from 2 companies
- 2024$9,688 · 5 payments from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Chiesi USA, Inc. | $7,038 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $107.11 | 1 |
What the 2025 payments were for
- Consulting Fee$6,900 · 1 payment
- Food and Beverage$244.74 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other neonatologists in Dallas
- 1033151238
- 1710305545
- 1801271069
- 1013447788
- 1053739912
- 1063831782
- 1164682712
- 1245551449
- 1306266200
- 1326373002
- 1376570317
- 1376986315
All 99 neonatologists in Dallas · All neonatologists in Texas